Dr Sulaiman Al Habib Medical Services Group Company SJSC 4013.SR · SAR
Health Care · Health Care Providers & Services · Tadawul · 🇸🇦 Saudi Arabia
214.20
-0.37%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dr Sulaiman Al Habib Medical Services Group Company SJSC
Its shares trade on Tadawul under the ticker 4013.SR. It has been listed since 26 February 2020. In the fiscal year to 31 December 2025, it reported revenue of SAR 13.71bn and net income of SAR 2.40bn. At that date it held total assets of SAR 23.21bn and shareholders' equity of SAR 7.90bn.
Dr. Sulaiman Al-Habib Medical Services Group Company is a Saudi Arabia-based company engaged in health care sector. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2020-02-26. The firm operates through it's subsidiaries in three segments: Hospitals, Pharmacies and Other. The Hospital segment is engaged in setting up, managing and operating hospitals, medical facilities, pharmacies and medical diagnostic and radiological laboratories. The Pharmacies segment operates Al Habib Pharmacies, Middle East Pharmacies Company and Afia Pharmacies Company. The Other segments include management and operations services for third party, home healthcare service, intensive care units, ambulatory transportation, facility maintenance services information technology and systems services, cloud solutions, among others. The firm also provides import and export, wholesale and retail sale of medicines, medical and herbal products, cosmetics, medical devices and equipment.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 26 Feb 2020
- Website
- hmg.com ↗
Leadership
Pay as last reported
- Dr. Sulaiman Abdulaziz Al HabibNon-Executive Chairman of the Board, FounderSAR 323,000
- Mr. Faisal Abdullah Ali Al NassarGroup Chief Executive Officer, Group Chief Financial Officer, Executive Director, since 2018SAR 230,000
- Mr. Obaid Abdullah Obaid Al RasheedNon-Executive Independent Vice Chairman of the BoardSAR 341,000
- Eng. Abdulelah Abdulrahman Saleh Al MaymanChief Executive Officer and Member of the Board of Managers of Hulool Al Sahabah for IT & Communication Company, since 2021
- Prof. Awad Abdullah Al OmariChief Medical Officer and Academic Affairs, Chief Executive Officer and Member of the Board of Managers of Rawabet Medical Company
- Mr. Abdulwahab Abdullah Mohammed Al AbdulwahabChief Operating Officer
- Eng. Ahmed Mohammed BabatinChief People Officer
- Prof. Abdullah Sulaiman Al HerbishSenior Vice President - Physician Affairs and Consultant Pediatric Endocrinologist and Diabetologist, Executive Director
- Prof. Sulaiman Abdul Aziz Sulaiman Al MajedSenior Vice President - Medical Affairs, Consultant of Internal and Chest Diseases and Supervisor of diagnostic radiology, laboratory and nursing, since 2022
- Mr. Riyadh Muhammad BajodahActing Vice President - Digital Business
- Eng. Mohamed Abdelmoula ShalabyVice President - Supply Chain
- Mr. Saud Abdulaziz Bin Mohammed Saleh Al ArifiGroup General Counsel, Secretary of the Board, since 2022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 68
- Environment
- 43
- Social
- 95
- Governance
- 65
- Direct emissions (scope 1)
- 7,796.89 t
- Energy emissions (scope 2)
- 93,358.42 t
- Value chain emissions (scope 3)
- 779,839.2 t
- Women in the workforce
- 58%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dr. Sulaiman Al-Habib Medical Services Group operates hospitals in Riyadh with 12 facilities.
- Al Habib Pharmacies and Afia Pharmacies Company serve multiple regions in Saudi Arabia.
- The company's hospital segment manages medical diagnostic and radiological laboratories.
Weaknesses
- The company's pharmacy segment relies on Middle East Pharmacies Company for operations.
- The Other segment includes home healthcare services with limited market penetration.
- The firm's information technology services face competition from local providers.
Opportunities
- Expanding hospital operations in Riyadh to meet growing healthcare demand.
- Increasing pharmacy network coverage across Saudi Arabia's urban centers.
- Introducing cloud solutions for medical data management in the Health Care sector.
Threats
- Riyadh's healthcare market faces increasing competition from new hospital entrants.
- Saudi Arabia's regulatory changes may impact pharmacy operations.
- Rising costs of medical equipment could affect profitability in the Health Care sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.